CRDL.TO
Cardiol Therapeutics Inc
Price:  
1.89 
CAD
Volume:  
91,073.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CRDL.TO WACC - Weighted Average Cost of Capital

The WACC of Cardiol Therapeutics Inc (CRDL.TO) is 5.8%.

The Cost of Equity of Cardiol Therapeutics Inc (CRDL.TO) is 5.85%.
The Cost of Debt of Cardiol Therapeutics Inc (CRDL.TO) is 5.00%.

Range Selected
Cost of equity 4.60% - 7.10% 5.85%
Tax rate 25.90% - 26.50% 26.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.6% - 7.1% 5.8%
WACC

CRDL.TO WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.18 0.4
Additional risk adjustments 0.5% 1.0%
Cost of equity 4.60% 7.10%
Tax rate 25.90% 26.50%
Debt/Equity ratio 0 0
Cost of debt 5.00% 5.00%
After-tax WACC 4.6% 7.1%
Selected WACC 5.8%